Dehydrogenation process

US10647637B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10647637-B2
Application numberUS-201816178413-A
CountryUS
Kind codeB2
Filing dateNov 1, 2018
Priority dateNov 2, 2017
Publication dateMay 12, 2020
Grant dateMay 12, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Large pill dehydrogenation catalysts and large screens slot width are combined in dehydrogenation units to reduce the pressure drop across the catalyst bed and reactor screens compared to conventional screen and catalyst size combinations. The catalyst has an average pill diameter in the range of 1.6 mm to 3.0 mm, and the slot width of the screen is in the range of about 30% to about 60% of the pill diameter.

First claim

Opening claim text (preview).

What is claimed is: 1. A process for dehydrogenation of a hydrocarbon feed comprising: providing a hydrocarbon feed stream comprising at least one paraffin to a dehydrogenation reactor, the reactor comprising a shell containing at least one screen; contacting the feed stream with a catalyst in the reactor under dehydrogenation conditions, the catalyst having an average pill diameter in a range of 1.6 mm to 3.0 mm, and wherein a catalyst-side screen slot width of the at least one screen is in a range of about 30% to about 60% of the pill diameter; and removing an effluent stream comprising at least one olefin from the reactor. 2. The process of claim 1 wherein the slot width is in the range of about 30% to about 40% of the average pill diameter. 3. The process of claim 1 wherein the screen slot width is in the range of about 40% to about 50% of the average pill diameter. 4. The process of claim 1 wherein the relative screen delta pressure drop in the screen slot width range is decreased by about 35-55% compared to a process having screen slot width in the range of about 30% to about 40% of the average pill diameter. 5. The process of claim 1 wherein the screen slot width is in the range of about 50% to about 60% of the average pill diameter. 6. The process of claim 1 wherein the relative screen delta pressure drop in the screen slot width range is decreased by about 50 to 65% compared to a process having screen slot width in the range of about 30% to about 40% of the average pill diameter. 7. The process of claim 1 wherein the relative delta pressure in the catalyst bed is decreased by at least 15% compared to a process using a catalyst having an average pill diameter of less than 1.6 mm. 8. The process of claim 1 wherein the relative delta pressure in the catalyst bed is decreased by at least 30% compared to a process using a catalyst having an average pill diameter of less than 1.6 mm. 9. The process of claim 1 wherein the relative delta pressure in the catalyst bed is decreased by at least 45% compared to a process using a catalyst having an average pill diameter of less than 1.6 mm. 10. The process of claim 1 wherein the relative delta pressure in the catalyst bed is decreased by at least 60% compared to a process using a catalyst having an average pill diameter of less than 1.6 mm. 11. The process of claim 1 wherein the catalyst has a higher piece crush strength than a catalyst having an average pill diameter of less than 1.6 mm. 12. The process of claim 1 wherein the catalyst has a lower apparent bulk density than a catalyst having an average pill diameter of less than 1.6 mm. 13. The process of claim 1 , further comprising at least one of: sensing at least one parameter of the process and generating a signal or data from the sensing; generating and transmitting a signal; or generating and transmitting data. 14. A process for dehydrogenation of a hydrocarbon feed comprising: providing a hydrocarbon feed stream comprising at least one paraffin to a dehydrogenation reactor, the reactor comprising a shell containing at least one screen; contacting the feed stream with a catalyst in the reactor under dehydrogenation conditions, the catalyst having an average pill diameter in a range of 1.6 mm to 3.0 mm, and wherein a catalyst-side screen slot width of the at least one screen is in a range of about 30% to about 60% of the pill diameter; removing an effluent stream comprising at least one olefin from the reactor; wherein the relative delta pressure in the catalyst bed is decreased by at least 15% compared to a process using a catalyst having an average pill diameter of less than 1.6 mm. 15. The process of claim 14 wherein the relative delta pressure in the catalyst bed is decreased by at least 30% compared to a process using a catalyst having an average pill diameter of less than 1.6 mm. 16. The process of claim 14 wherein the relative delta pressure in the catalyst bed is decreased by at least 60% compared to a process using a catalyst having an average pill diameter of less than 1.6 mm. 17. The process of claim 14 wherein the relative screen delta pressure drop in the screen slot width range is decreased by about 35-55% compared to a process having screen slot width in the range of about 30% to about 40% of the average pill diameter. 18. The process of claim 14 wherein the relative screen delta pressure drop in the screen slot width range is decreased by about 50 to 65% compared to a process having screen slot width in the range of about 30% to about 40% of the average pill diameter. 19. The process of claim 14 wherein the catalyst has a higher piece crush strength than a catalyst having an average pill diameter of less than 1.6 mm, or wherein the catalyst has a lower apparent bulk density than a catalyst having an average pill diameter of less than 1.6 mm, or both. 20. A dehydrogenation reactor comprising: a shell having a feed inlet and an effluent outlet, the shell containing a pair of screens; and a catalyst having an average pill diameter in a range of 1.6 mm to 3.0 mm, and wherein a catalyst-side screen slot width of the pair of screens is in a range of about 30% to about 60% of the pill diameter, wherein the catalyst has a higher piece crush strength than a catalyst having an average pill diameter of less than 1.6 mm, or wherein the catalyst has a lower apparent bulk density than a catalyst having an average pill diameter of less than 1.6 mm, or both, the catalyst positioned between the pair of screens.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10647637B2 cover?
Large pill dehydrogenation catalysts and large screens slot width are combined in dehydrogenation units to reduce the pressure drop across the catalyst bed and reactor screens compared to conventional screen and catalyst size combinations. The catalyst has an average pill diameter in the range of 1.6 mm to 3.0 mm, and the slot width of the screen is in the range of about 30% to about 60% of the…
Who is the assignee on this patent?
Uop Llc
What technology area does this patent fall under?
Primary CPC classification C07C5/3337. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).